Trial Profile
A Double-Blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2024
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Asthma; Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 11 Sep 2009 New trial record